Concept · Learn
What Peptides Are FDA Approved? The Real List
What peptides are FDA approved? In the United States, approved peptide medicines include semaglutide, tirzepatide, liraglutide, insulin products, tesamorelin, setmelanotide, and bremelanotide, among others. Approval belongs to a specific drug product and use—not every vial containing the same peptide. Most peptides sold online as “research use only” are not approved.
Which peptide medicines are FDA-approved?
FDA-approved peptide medicines span diabetes, obesity, hormone disorders, cancer care, bone disease, sexual health, and several rare conditions. The list below gives useful current examples, not every peptide product ever approved. FDA approval attaches to a finished product with a label, manufacturer, formulation, and permitted indication; it is not a gold star awarded to a molecule in every possible form. Current primary sources beat copied lists that quietly go stale.
| Medical use | FDA-approved peptide examples |
|---|---|
| Diabetes and weight management | Insulin products, glucagon, pramlintide, exenatide, liraglutide, dulaglutide, semaglutide, and tirzepatide |
| Hormone and endocrine care | Desmopressin, oxytocin, leuprolide, goserelin, triptorelin, octreotide, lanreotide, pasireotide, and tesamorelin |
| Bone disease | Calcitonin, teriparatide, and abaloparatide |
| Rare obesity disorders | Setmelanotide (Imcivree), including labeled genetic, syndromic, and acquired hypothalamic obesity indications |
| Other approved uses | Bremelanotide, linaclotide, plecanatide, teduglutide, icatibant, enfuvirtide, and ziconotide |
The names getting the most attention are real prescription drugs. DailyMed lists semaglutide products including Ozempic, Rybelsus, and Wegovy, while tirzepatide labels cover Mounjaro and Zepbound. Liraglutide is sold under labels including Victoza and Saxenda. These medicines earned approval for stated uses; “peptide” is their chemistry, not a separate regulatory shortcut.
Is sermorelin FDA-approved now?
Sermorelin needs an asterisk: Geref (sermorelin acetate) was FDA-approved, but the branded products were discontinued and there is no currently marketed FDA-approved sermorelin product. FDA later determined that Geref was not withdrawn for safety or effectiveness reasons. That history does not turn today’s compounded sermorelin into an FDA-approved finished drug.
This is why lists that simply call sermorelin “FDA-approved” mislead without being entirely invented. The 2013 Federal Register notice preserves the distinction: prior approval is real, discontinuation is real, and FDA said the withdrawal was not based on safety or effectiveness. Three facts, one awkward footnote.
Is PT-141 FDA-approved?
Bremelanotide is FDA-approved as the prescription product Vyleesi for acquired, generalized hypoactive sexual desire disorder in premenopausal women. PT-141 is another name commonly used for bremelanotide, but a vial of “PT-141” research powder is not Vyleesi and is not FDA-approved. Same active molecule does not mean same regulated product.
The Vyleesi label also limits what can honestly be claimed: the approval is not for men, postmenopausal women, erectile dysfunction, or general sexual-performance enhancement. Our bremelanotide/PT-141 profile keeps the approved medicine and the research market in separate lanes.
Which popular research peptides are not FDA-approved?
Popular research peptides including BPC-157, TB-500, CJC-1295, ipamorelin, MOTS-c, injectable GHK-Cu, AOD-9604, Semax, Selank, Epitalon, and Melanotan II are not FDA-approved drugs. “Research use only” means the seller is offering a laboratory material, not an FDA-reviewed medicine for people. Availability online does not change that status.
The FDA’s compounding safety-risk list names many of these substances and describes gaps involving human safety data, immune reactions, aggregation, or peptide-related impurities. That does not prove every research peptide is ineffective. It means FDA has not approved a finished drug after reviewing evidence for a particular use. BPC-157’s profile, for example, separates its active research story from its unapproved status.
Are compounded or “research-grade” versions approved?
Compounded and research-grade versions are not FDA-approved, even when their labels name an active ingredient found in an approved medicine. FDA states plainly that it does not approve compounded drugs. A compounded semaglutide preparation therefore does not inherit Ozempic or Wegovy’s approval, and loose bremelanotide powder does not inherit Vyleesi’s.
This product-level rule is the cleanest way to read the market. Ask for the exact product, label, manufacturer, and approved indication—not just the peptide name. The FDA’s explanation of what “FDA approved” means is blunt on this point: approval follows agency review of a drug for its intended use. Chemistry alone cannot smuggle a vial across that line.
Is FDA approval the same as being legal?
FDA approval and legality are different questions. Approval asks whether FDA reviewed and authorized a particular drug product for a stated use. Legality can instead involve possession, prescribing, pharmacy compounding, marketing, importation, or sports rules. A substance can be unapproved without being a federally controlled drug, and a prescription medicine can still be restricted to pharmacy dispensing.
That distinction is covered in are peptides legal?. For a dated, compound-by-compound view, use the regulatory status reference. The short version is less satisfying but more accurate: check the exact product and indication, not a vendor’s use of the word “peptide,” and treat any undated approval list as perishable.